Skip to main content
Clinical Trials/NCT05111496
NCT05111496
Unknown
Not Applicable

Evaluation of the Radiological Dose Delivered to Risky Interventional Cardiology Patients (Optidose)

Ramsay Générale de Santé1 site in 1 country85 target enrollmentSeptember 24, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
X-rays; Effects
Sponsor
Ramsay Générale de Santé
Enrollment
85
Locations
1
Primary Endpoint
Dose measured to the patient's skin at the entrance to the X-ray beam
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is therefore to study the actual doses of X-rays delivered to the patient's skin during recanalization of a coronary artery in a context of Chronic Total Occlusion

Registry
clinicaltrials.gov
Start Date
September 24, 2020
End Date
November 24, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient over 18 years-old
  • Patient requiring intervention with a predicted risk of exceeding the radiological threshold (Air Kerma\> 3Gy): complex coronary dilation, coronary recanalization
  • Patient benefiting from a social protection insurance
  • Patient having been informed and not objecting to this research

Exclusion Criteria

  • Patient refusal to participate in the study
  • Patient with known radiosensitivity factors (eg: Lupus)
  • Patient having had radiotherapy treatment of the thoracic region.
  • Patient whose sum of radiation doses to the skin\> 0.5 Gy in the thoracic region in the 3 months preceding inclusion.
  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant or breastfeeding woman
  • Patient hospitalized without consent.

Outcomes

Primary Outcomes

Dose measured to the patient's skin at the entrance to the X-ray beam

Time Frame: 1 month

Dose expressed in Gy (Peak skin dose).

Study Sites (1)

Loading locations...

Similar Trials